SMB to midsize SoBran BioScience operates with 501-1000 employees and annual revenue in the 10M-25M range, indicating a mid-market profile with growing demand for scalable biomedical services and compliance solutions. Opportunity areas include expanding their contract research, vaccine development support, and hazardous-protection programs.

Quality and Compliance The company is ISO 9001:2008 certified and emphasizes uncompromised quality and service in biomedical, engineering, logistics, and hazard protection. This highlights a potential for premium service partnerships, certification-driven audits, and long-term multi-year frameworks that leverage their quality standards.

Public Sector Ties Their client base includes government and large institutions such as the NIH and DHS, signaling a proven track record with regulated environments. This suggests sales opportunities in government-related contracts, compliance accelerators, and secure logistics or SafeMail program expansions.

Integrated Capabilities SoBran supports scientists, logistics operations, and employee safety, indicating cross-sell potential across multiple service lines such as biosafety logistics, vaccine support programs, and hazard-protection solutions for facilities and campuses.

Competitive Landscape With peers ranging from regional players to global CROs and biotech service firms, SoBran sits near the lower-to-mid tier of revenue among comparables but with a focused niche in safety and logistics. This creates opportunities for targeted partnerships, alliance opportunities, and differentiated value propositions in cost-conscious but quality-driven procurement cycles.